Covered recipient · General Payments record
THERESA NICOLE ROLNIAK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$458.42
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $458.42 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.41 | 9 |
| Gilead Sciences, Inc. | $108.64 | 1 |
| GENZYME CORPORATION | $58.47 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.86 | 3 |
| AIMMUNE THERAPEUTICS, INC. | $49.55 | 2 |
| QOL Medical, LLC | $24.49 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $458.42 | 18 |
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.30 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109308 | CMS |
| ABBVIE INC. | $14.72 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109310 | CMS |
| ABBVIE INC. | $25.33 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109312 | CMS |
| ABBVIE INC. | $16.93 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109314 | CMS |
| ABBVIE INC. | $17.35 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109316 | CMS |
| ABBVIE INC. | $17.11 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109318 | CMS |
| ABBVIE INC. | $21.02 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109320 | CMS |
| ABBVIE INC. | $18.03 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109322 | CMS |
| ABBVIE INC. | $24.62 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108109324 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $28.46 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000225 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $21.09 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000393 | CMS |
| GENZYME CORPORATION | $27.64 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140003395 | CMS |
| GENZYME CORPORATION | $30.83 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140003373 | CMS |
| Gilead Sciences, Inc. | $108.64 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133696755 | CMS |
| QOL Medical, LLC | $24.49 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147746116 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.68 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137816468 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.06 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137816470 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.12 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137816472 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.